November 3, 2010

Swiss drug maker Biogen Idec and U.S. drug maker Cardiokine have terminated an agreement to...

September 28, 2010

The drug market for Crohn's disease treatments will see moderate growth over the next decade,...

September 8, 2010

NEW YORK British drug maker GlaxoSmithKline and biotech company Genmab have started a late-stage trial...

August 18, 2010

Swiss drug maker Biogen Idec will develop and commercialize an investigational drug as a treatment...

August 8, 2010

Generic drug maker Dr. Reddy’s has launched in India the world’s first follow-on version of...

July 7, 2010

A big-ticket acquisition could be in the works for French drug maker Sanofi-Aventis, according to...

May 24, 2010

Generic drug maker Teva Pharmaceutical Industries isn’t holding back in its effort to push into...

May 23, 2010

Swiss biotech company Biogen Idec and U.S. drug maker Abbott have begun enrolling patients in...

March 25, 2010

Swiss drug maker Biogen Idec and Irish drug maker Elan Corp. have started enrolling patients...

March 22, 2010

Biogen Idec appointed a nominee of billionaire investor Carl Icahn to its board Monday, the...

March 9, 2010

Abbott will acquire Facet Biotech for $450 million, the drug maker announced Wednesday....

March 7, 2010

Roche and Biogen Idec are suspending trials of a drug for treating autoimmune disorders amid...

February 18, 2010

The Food and Drug Administration has approved a drug made by Roche subsidiary Genentech and...

January 21, 2010

The Food and Drug Administration has approved a new drug for improving walking ability in...

January 20, 2010

An investigational drug for treating multiple sclerosis reduced progression of disability by more than 30%,...

January 11, 2010

Biogen Idec hopes to win approval for a multiple sclerosis drug in Canada and the...